Literature DB >> 30106013

Benefits of orchidopexy on the fertility of adult men with bilateral cryptorchidism.

Yan Zhang1, Wei Huang1, Zheng-Hui Hu1, Min Cao1, Hong-Shen Wu1, Jun-Jie Cao1, Fei-Fan Wang1, Xiao-Dong Jin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30106013      PMCID: PMC6219294          DOI: 10.4103/aja.aja_63_18

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


× No keyword cloud information.
Dear Editor, The incidence of cryptorchidism is approximately 0.8% at 1 year of age and remains at this level throughout adulthood. One-third of these patients have bilaterally cryptorchid testes.1 Most patients with cryptorchidism have this condition corrected by surgery before puberty. Therefore, adult bilateral cryptorchidism (BC) is not observed frequently in clinical practice. Bilateral undescended testes are commonly associated with azoospermia and male infertility. Orchiopexy is usually considered a cosmetic operation and to reduce cancer risk when performed in adult men, and is generally thought to have no effect on spermatogenic recovery. We conducted a single-center retrospective study to evaluate the efficacy of orchidopexy and its effect on fertility in adult men with BC. Between January 2011 and December 2016, we retrospectively reviewed the medical records of 31 adult men who underwent surgical treatment for BC at the First Affiliated Hospital, Zhejiang University School of Medicine (Hangzhou, China). Three patients were excluded because of testicular seminoma (two cases) and unilateral testicular absence (one case). All patients had a one-stage operation. All procedures in our study were performed by experienced surgeons. According to the location of testicles, preoperative examination results, and doctors’ experience, open or laparoscopic surgery was selected. Twenty-three patients with BC underwent bilateral orchidopexy, whereas five patients with BC underwent unilateral orchidopexy and contralateral orchiectomy. Preoperative data collection included the location of the testis, testicular size, serum testosterone (T) levels, and semen analysis. Six patients (21.4%, 6/28) declined participation after bilateral orchidopexy. Twenty-two postoperative men had a single hospital visit in August 2017 to record medical history, physical examination, scrotal ultrasound, serum T levels, and semen analysis. The mean follow-up period after operation was 22.3 (standard deviation [s.d.]: 9.8, range: 8.5–45.0) months. All participants provided written informed consent, and all procedures were approved by the Bioethics Committee for Research on Human Beings of the First Affiliated Hospital of Zhejiang University School of Medicine. All statistical analyses were performed with SPSS®, version 15.0 (SPSS Inc., Chicago, IL, USA). A t-test (paired comparisons) was used to compare serum T levels and testicular volumes before and after surgery. Statistical significance was defined as P < 0.05. Twenty-eight patients were enrolled in this study. The mean age at operation was 24.9 (s.d.: 6.0, range: 18–43) years. The preoperative locations of the 56 cryptorchid testes were inguinal (44.6%, 25/56), prepubic (21.4%, 12/56), or intra-abdominal (33.9%, 19/56). In all patients with BC, the preoperative seminal analysis showed azoospermia. Twenty-two (78.6%, 22/28) patients were followed up. Ejaculated spermatozoa were obtained in three patients (13.6%, 3/22) after orchidopexy (). To exclude the influence of orchiectomy, we only analyzed the serum T level and testicular volume in 17 patients with BC undergone bilateral orchidopexy. Preoperative and postoperative mean testicular volumes were 4.5 (s.d.: 2.4, range: 1.0–12.0) ml and 4.1 (s.d.: 2.3, range: 1.0–11.0) ml, respectively. Preoperative and postoperative mean serum T levels were 389.9 (s.d.: 118.0, range: 235.3–611.8) ng dl−1 and 350.4 (s.d.: 95.3, range: 224.0–590.0) ng dl−1, respectively. No significant differences were found in T levels and testicular volumes after surgery compared with those preoperatively (P = 0.06). The main reasons to treat undescended testes are to increase fertility and to decrease the risks of testicular torsion, testicular injury, and testicular cancer, as well as psychological stigma.1 Current guidelines recommend that orchiopexy should be performed before the age of 18 months. Most published data indicate that testes remaining undescended at a postpubertal age are nonfunctional and that fertility rates are not improved after postpubertal repair.2 However, most patients included in this analysis exhibited unilateral cryptorchidism. Orchiopexy for adult patients is usually considered a cosmetic operation that provides a palpable testis for examination rather than to induce spermatogenesis. Chiba et al.3 previously reported that 10 patients with bilateral adult cryptorchidism showed azoospermia. After orchidopexy, ejaculated spermatozoa could not be obtained from any patient. Microdissection testicular sperm extraction (TESE) was performed in four of the 10 patients, but spermatozoa could not be retrieved from any patient.3 However, recent evidence indicates that postpubertal orchiopexy may allow fertility for patients with BC. We reviewed five related reports in which six cases had shown the successful initiation of spermatogenesis after adult bilateral orchiopexy.4568 In these six cases, one patient produced a naturally conceived pregnancy8, and four patients achieved pregnancy through assisted reproduction.4567 In our group, ejaculated spermatozoa were obtained from three patients after orchidopexy. One patient was married and naturally conceived 2 years after surgery, though the couple had an artificial abortion. The other two patients were unmarried. It is possible that altered environmental conditions, such as the lower temperature of testes after orchiopexy, may induce spermatogenesis. Five testicles were successfully descended by open surgery, and one testicle was removed by laparoscopy. The five treated undescended testes of the three patients were originally located in the inguinal canal. Undescended testes occupying the inguinal canal may have a higher fertility rate after orchiopexy. All three patients had T levels within the normal range. The oldest patient was 31 years of age. Youth and normal T levels may play important roles in maintaining the spermatogenic potential of testes. The shortest follow-up was 8 months, so a certain amount of time after orchiopexy may be necessary for the testes to recover spermatogenic ability. These results showed that it is possible to obtain spermatozoa from males with BC treated by orchiopexy after puberty. The development of TESE and intracytoplasmic sperm injection (ICSI) has advanced the treatment of extreme subfertility in men. Our study in combination with recent literature9 indicates that orchiopexy provides the opportunity for adult men exhibiting BC to conceive naturally or by assisted reproduction. There are some limitations in our study. First, this study was retrospective, which may cause recall bias. Second, the sample size was small and follow-up time was short. We will continue to expand the sample size. In summary, our study indicates that ejaculated spermatozoa can be obtained from adults after orchiopexy for BC, providing the opportunity for natural pregnancy or assisted reproduction.

AUTHOR CONTRIBUTIONS

XDJ, YZ, and WH contributed to the conception and design of the study. YZ WH, and ZHH acquired the data. YZ, WH, and FFW drafted the manuscript. MC, HSW, JJC, and FFW revised it for intellectual content. All authors read and approved the final manuscript. Clinical characteristics of three patients obtained ejaculated spermatozoa

COMPETING INTEREST

All authors declared no competing interests.
Table 1

Clinical characteristics of three patients obtained ejaculated spermatozoa

  9 in total

1.  Initiation of sperm production after bilateral orchiopexy: clinical and biological implications.

Authors:  A Giwercman; L L Hansen; N E Skakkebaek
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

Review 2.  Cryptorchidism: diagnosis, treatment, and long-term prognosis.

Authors:  Thomas F Kolon; Rakesh P Patel; Dale S Huff
Journal:  Urol Clin North Am       Date:  2004-08       Impact factor: 2.241

3.  The efficacy of adult orchidopexy as a treatment of male infertility: our experience of 20 cases.

Authors:  Koji Chiba; Tomomoto Ishikawa; Kohei Yamaguchi; Masato Fujisawa
Journal:  Fertil Steril       Date:  2009-05-12       Impact factor: 7.329

4.  Achieved pregnancy with the delivery of a healthy child by TESE-ICSI 7 years after bilateral adult orchidopexy: a case report.

Authors:  K Matsushita; K Yamaguchi; F Li; K Okada; M Ando; K Chiba; M Koshida; H Miyake; M Fujisawa
Journal:  Andrologia       Date:  2013-10-10       Impact factor: 2.775

5.  Fertility after correction of bilateral undescended testes at the age of 23 years.

Authors:  N D Heaton; M Davenport; J P Pryor
Journal:  Br J Urol       Date:  1993-04

6.  Induction of spermatogenesis and pregnancy after adult orchiopexy.

Authors:  D Shin; G E Lemack; M Goldstein
Journal:  J Urol       Date:  1997-12       Impact factor: 7.450

7.  The role of orchiectomy in the management of postpubertal cryptorchidism.

Authors:  E Rogers; S Teahan; H Gallagher; M R Butler; R Grainger; T E McDermott; J A Thornhill
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

8.  Successful testicular sperm extraction and paternity in an azoospermic man after bilateral postpubertal orchiopexy.

Authors:  Y M Lin; C C Hsu; M H Wu; J S Lin
Journal:  Urology       Date:  2001-02       Impact factor: 2.649

9.  Testicular sperm extraction with intracytoplasmic sperm injection is successful for the treatment of nonobstructive azoospermia associated with cryptorchidism.

Authors:  Jay D Raman; Peter N Schlegel
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

  9 in total
  1 in total

Review 1.  Transverse testicular ectopia: two rare adult cases and a review of literature.

Authors:  Milap Shah; Aviansh Odugoudar; Arun Chawla; Zeeshan Bm Hameed
Journal:  BMJ Case Rep       Date:  2020-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.